THERMO FISHER SCIENTIFIC INC.Underwriting Agreement • November 7th, 2014 • Thermo Fisher Scientific Inc. • Measuring & controlling devices, nec • New York
Introductory. Thermo Fisher Scientific Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”), acting severally and not jointly, the respective amounts set forth in such Schedule A of $800,000,000 aggregate principal amount of the Company’s 3.300% Senior Notes due 2022 (the “Notes”). Merrill Lynch, Pierce, Fenner & Smith Incorporated, Mitsubishi UFJ Securities (USA), Inc., Citigroup Global Markets Inc. and Credit Suisse Securities (USA) LLC have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Notes.
